Compare Cognizant Technology Solutions Corp (CTSH) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cognizant Technology Solutions Corp vs Humana Inc — how do they compare? Cognizant Technology Solutions Corp trades at $59.2 (market cap $27.03B), while Humana Inc trades at $431.03 (market cap $46.49B). The key difference: Humana Inc is the larger of the two by market cap, and Cognizant Technology Solutions Corp pays the higher dividend (2.2%). Which is the better fit depends on your goals — on Pluang, investors hold Cognizant Technology Solutions Corp for 57 Days and Humana Inc for 51 Days on average.
| CTSH | HUM | |
|---|---|---|
Market Cap | $27.03B | $46.49B |
Volume | 9,883,888 | 2,567,704 |
Sector | Technology | Health |
52-Week High | $86.70 | $409.85 |
52-Week Low | $38.73 | $163.67 |
Typical Hold Time | 57 Days | 51 Days |
Enterprise Value | $28.08B | $53.84B |
Dividend Yield | 2.2% | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CTSH trades at $60.01, up 5.15% with a bullish technical signal. Recent earnings beat expectations in Q4 2025 and Q1 2026, though Q2 2026 missed. The company shows solid fundamentals with a P/E of 12.88 and net income margin of 10.26%. Positive news includes AI partnerships and employer awards, supporting investor confidence.
The outlook is positive with a consensus price target of $64.25, indicating potential upside. Risks include competitive pressures in IT services and reliance on AI adoption. Strong cash flow and low debt bolster stability, but market volatility and economic headwinds remain concerns for sustained growth.
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
